PHARMA MAR, S.A. «12» Page 1 out of 2 09/02/2024 08:25 PHARMA MAR, S.A. On business and financial situation Sylentis, a subsidiary of Pharma Mar, reports that the Phase III clinical trial with tivanisiran in patients with dry eye disease associated with Sjögren's syndrome has not met its primary endpoint. Register number: 2108 16/02/2023 08:25 PHARMA MAR, S.A. On business and financial situation The Company announces the closure of the Phase III “Neptuno” trial with plitidepsin for the treatment of COVID-19 in hospitalized patients. Register number: 1759 13/04/2021 08:27 PHARMA MAR, S.A. On credit ratings Axesor raises long-term credit rating of Pharma Mar. Register number: 840 03/12/2020 08:22 PHARMA MAR, S.A. On business and financial situation The company announces results of the ATLANTIS phase III study with lurbinectedin Register number: 615 10/11/2020 08:25 PHARMA MAR, S.A. On business and financial situation The company sends communication of inside information at the request of the CNMV Register number: 565 03/11/2020 08:19 PHARMA MAR, S.A. On P&L The Company sends press release regarding the Q3 2020 results Register number: 550 16/10/2020 08:37 PHARMA MAR, S.A. On business and financial situation The Company announces positive results of its APLICOV trial against COVID-19 Register number: 496 30/07/2020 13:06 PHARMA MAR, S.A. On P&L The Company sends press release regarding first half 2020 results. Register number: 398 15/06/2020 21:35 PHARMA MAR, S.A. On business and financial situation Pharma Mar reports that the FDA has approved lurbinectedin for the treatment of metastatic small cell lung cancer under “accelerated approval” regulation. Register number: 284 Related to communication no. 15 dated 17/02/2020 (08:28) 29/04/2020 08:31 PHARMA MAR, S.A. On business and financial situation Pharma Mar and Immedica Pharma have entered into an exclusive agreement for the distribution and marketing of the lurbinectedin in the UK, Ireland, the Nordic countries, some countries within Eastern Europe, the Middle East and North Africa. Register number: 197 Page 1 out of 2 «12»